What's in Appili Therapeutics Inc.'s pipeline?

Appili Therapeutics Inc. has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Appili Therapeutics Inc.'s portfolio?

Top competitors by shared drug class: Balmoral Medical company, Dongfang Hospital Beijing University of Chinese Medicine, Johns Hopkins Bloomberg School of Public Health, LEO Pharma, National Taiwan University Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/appili-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Appili Therapeutics Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Appili Therapeutics Inc. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Metronidazole Tablet	Metronidazole Tablet	marketed	Nitroimidazole antibiotic	Bacterial and parasitic DNA	Infectious Disease

Therapeutic area mix

Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Balmoral Medical company · 1 shared drug class
Dongfang Hospital Beijing University of Chinese Medicine · 1 shared drug class
Johns Hopkins Bloomberg School of Public Health · 1 shared drug class
LEO Pharma · 1 shared drug class
National Taiwan University Hospital · 1 shared drug class
Sherief Abd-Elsalam · 1 shared drug class
University of Alabama at Birmingham · 1 shared drug class
University of Guarulhos · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Appili Therapeutics Inc.:

Cite this brief

Drug Landscape (2026). Appili Therapeutics Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/appili-therapeutics-inc. Accessed 2026-05-16.